The
cancer world has been shaken by a debate over the merits of screening mammography
for breast cancer. Drs. Peter C. Goetzsche and Ole Olsen of the Nordic Cochrane
Collaboration in Copenhagen reviewed all the clinical trials for mammography.
They concluded, in the medical journal, the Lancet, that "there is
no reliable evidence that screening for breast cancer reduces mortality."
In late January, 2002, a branch of the US National Cancer Institute agreed
with them that the "evidence justifying mammography was shaky."
The
Cochrane Collaboration, the Lancet and the NCI are bastions
of orthodox medicine. Because of this, even the New York Times joined in
the attack (January 27, 2002). In a lead editorial, "Uncertainty Over Mammograms,"
the Times questioned the likelihood of ever getting an honest answer to
the question of whether or not mammography is a worthwhile screening technique.
"It
may not be easy to get a truly independent review," they wrote. "Mammography
has been so strongly endorsed by the cancer establishment and has become such
a significant source of revenue and patients for many hospitals and doctors that
it may be difficult to excise without overwhelming evidence that it is dangerous."
(Dangerous? This is odd, since the Cochrane researchers did not say that mammography
is dangerous, only that it is ineffective.)
How
amazing to hear the Times speak of "the cancer establishment."
And that establishment was not slow in responding. Four days later, ten US medical
groups, including the American Cancer Society and the American Medical
Association, placed a full-page ad in the New York Times, supporting
mammography. The ad coincided with an article by Claudia Henschke, MD, of Cornell
Medical Center, also published in the Lancet, which analyzed one 1988 clinical
trial from Malmoe, Sweden. She concluded that mammography did, indeed, reduce
deaths.
How
could these researchers be so far apart in analysis of the same studies? Because
Goetzsche and Olsen looked at all the people who had died of any causes, while
Henschke looked only at people who had specifically died of breast cancer in one
study, and ignored all other causes of death. This is
comparing apples and oranges. Overall survival is a more meaningful
outcome than disease-specific survival. The reason is that the treatments themselves
may cause deaths. (Even Henschke concedes that early detection and treatment may
be associated with "somewhat increased mortality" in earlier years).
By failing to take account of all causes of death one conveys an unduly positive
estimate of the intervention.
Expect
to see an escalating campaign to counteract the negative findings. The establishment
will pull out all of the stops on this one, because mammography is the centerpiece
of the whole orthodox strategy on breast cancer. On the ABC Evening News,
I heard a prominent doctor from Memorial Sloan-Kettering sternly warn that women
would die if they listened to Goetzsche and Olsen's arguments. Dr. Tim Johnson,
the network's resident MD, strongly urged women to continue getting their mammograms
(2/1/02). He conveyed the impresson that even the Lancet now admits that
mammography works."
Yet
here is the actual opinion of the Lancet's editor-in-chief, Richard Horton,
MD. "The public believes mammography to be far more effective than it really
is," he said. "Women deserve an accurate assessment of the benefits
or harm from screening mammography. That means encouraging an open debate about
the issue."
Note
from Chet: Be sure to sign up for Dr. Moss's excellent newsletter at his website.
Click
Here to
share this page with your friends, website visitors, ezine readers, social followers
and other online contacts.
Disclaimer:
Throughout this website, statements are made pertaining to the properties and/or
functions of food and/or nutritional products. These statements have not been
evaluated by the Food and Drug Administration and these materials and products
are not intended to diagnose, treat, cure or prevent any disease.